ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,03
-0,17%
Dow Jones
43 428,02
-1,69%
DAX
22 461,74
0,89%
Brent Oil
74,095
-0,01%
Bitcoin
95 887,09
-0,40%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Elite Pharmaceuticals Inc (QB) (ELTP) Cours

Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals Inc (QB) (ELTP)

USOTC
0,48745
-0,00955
(-1,92%)
Fermé 24 Février 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,48745
Prix Achat
0,4526
Prix Vente
0,628
Volume échangé
540 081
0,4727 Fourchette du Jour 0,509
0,1213 Plage de 52 semaines 0,7598
Cap du marché
520,73M
Clôture Veille
0,497
Ouverture
0,509
Dernière Transaction
200
@
0.48745
Dernière heure de transaction
Volume financier
US$ 262 745
VWAP
0,486492
Volume moyen (3 m)
1 298 390
Actions en circulation
1 068 273 108
Rendement du Dividende
-
Ratio Cours sur Bénéfices
26,06
Bénéfice par action (BPA)
0,02
Chiffre d'affairess
56,63M
Bénéfice net
20,11M

À propos de Elite Pharmaceuticals Inc (QB)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma... Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops niche generic products. Elite specializes in developing and manufacturing oral, controlled-release drug products. Elite owns multiple generic products which have been licensed to Lannett Company, Prasco, LLC, Epic Pharma, LLC, and TAGI Pharma. Elite operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. For more information, visit www.elitepharma.com. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.elitepharma.com
Siège social
Carson City, Nevada, USA
Fondé
-
Elite Pharmaceuticals Inc (QB) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker ELTP. Le dernier cours de clôture d'Elite Pharmaceuticals (QB) était de US$0,50. Au cours de la dernière année, les actions de Elite Pharmaceuticals (QB) ont été négociées dans une fourchette de prix de US$ 0,1213 à US$ 0,7598.

Elite Pharmaceuticals (QB) compte actuellement 1 068 273 108 actions en circulation. La capitalisation boursière d'Elite Pharmaceuticals (QB) est de US$530,93 million. Elite Pharmaceuticals (QB) a un ratio cours/bénéfice (ratio PE) de 26.06.

ELTP Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
13 Février 2025
ELTP (-1,92%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
13 Février 2025
ELTP (-1,92%)

Form 8-K - Current report
Edgar (US Regulatory)
26 Décembre 2024
ELTP (-1,92%)

Form 8-K - Current report
Edgar (US Regulatory)
02 Décembre 2024
ELTP (-1,92%)

Form 8-K - Current report
Edgar (US Regulatory)
18 Novembre 2024
ELTP (-1,92%)

Form 8-K - Current report
Edgar (US Regulatory)
14 Novembre 2024
ELTP (-1,92%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
14 Novembre 2024
ELTP (-1,92%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
28 Octobre 2024
ELTP (-1,92%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
23 Octobre 2024
ELTP (-1,92%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.037358.298155965340.45010.5550.44525294320.50966196CS
4-0.00255-0.5204081632650.490.560.44512462490.50879468CS
12-0.09505-16.31759656650.58250.6450.44512983900.52643972CS
260.29255150.1026167270.19490.75980.1867524878550.47927767CS
520.30005160.1120597650.18740.75980.121316080300.40694672CS
1560.448651156.314432990.03880.75980.026810074330.25982932CS
2600.39745441.6111111110.090.75980.0239772360.18250627CS

ELTP - Frequently Asked Questions (FAQ)

What is the current Elite Pharmaceuticals (QB) share price?
The current share price of Elite Pharmaceuticals (QB) is US$ 0,48745
How many Elite Pharmaceuticals (QB) shares are in issue?
Elite Pharmaceuticals (QB) has 1 068 273 108 shares in issue
What is the market cap of Elite Pharmaceuticals (QB)?
The market capitalisation of Elite Pharmaceuticals (QB) is USD 530,93M
What is the 1 year trading range for Elite Pharmaceuticals (QB) share price?
Elite Pharmaceuticals (QB) has traded in the range of US$ 0,1213 to US$ 0,7598 during the past year
What is the PE ratio of Elite Pharmaceuticals (QB)?
The price to earnings ratio of Elite Pharmaceuticals (QB) is 26,06
What is the cash to sales ratio of Elite Pharmaceuticals (QB)?
The cash to sales ratio of Elite Pharmaceuticals (QB) is 9,25
What is the reporting currency for Elite Pharmaceuticals (QB)?
Elite Pharmaceuticals (QB) reports financial results in USD
What is the latest annual turnover for Elite Pharmaceuticals (QB)?
The latest annual turnover of Elite Pharmaceuticals (QB) is USD 56,63M
What is the latest annual profit for Elite Pharmaceuticals (QB)?
The latest annual profit of Elite Pharmaceuticals (QB) is USD 20,11M
What is the registered address of Elite Pharmaceuticals (QB)?
The registered address for Elite Pharmaceuticals (QB) is 321 W. WINNIE LANE, #104, CARSON CITY, NEVADA, 89703
What is the Elite Pharmaceuticals (QB) website address?
The website address for Elite Pharmaceuticals (QB) is www.elitepharma.com
Which industry sector does Elite Pharmaceuticals (QB) operate in?
Elite Pharmaceuticals (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
RQHTFReliq Health Technologies Inc (CE)
US$ 0,02
(1 999 900,00%)
1,75k
AMMJAmerican Cannabis Company Inc (CE)
US$ 0,001
(99 900,00%)
25,8k
SDCCQSmileDirectClub Inc (CE)
US$ 0,0004
(39 900,00%)
84,16k
SLNAFSelina Hospitality PLC (CE)
US$ 0,0002
(19 900,00%)
17,8k
AMBSAmarantus Bioscience Holdings Inc (CE)
US$ 0,0001
(9 900,00%)
6,63M
ZPASZoompass Holdings Inc (CE)
US$ 0,000001
(-100,00%)
125,1k
GSVIGSV Inc (CE)
US$ 0,000001
(-99,99%)
100
SRWRFSolarworld Ag (CE)
US$ 0,000001
(-99,92%)
2k
HJGPHanjiao Group Inc (CE)
US$ 0,000001
(-99,67%)
1,58k
MTQCFMTQ Corporation Ltd (PK)
US$ 0,0011
(-99,45%)
4,9k
TSOITherapeutic Solutions International Inc (PK)
US$ 0,0004
(100,00%)
174,55M
ASIIAccredited Solutions Inc (PK)
US$ 0,0004
(-11,11%)
125,46M
PHILPHI Group Inc (PK)
US$ 0,0002
(0,00%)
118,06M
HMBLHUMBL Inc (PK)
US$ 0,0004
(-20,00%)
116,76M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,00276
(2,22%)
103,83M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces